US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
Related articles
Australia as Bangladesh vow to boost trade as foreign ministers meet in Dhaka
DHAKA, Bangladesh (AP) — Australia and Bangladesh on Tuesday said that the two countries would work2024-05-22- Sheridan Smith's under-fire West End play Opening Night could reportedly be cut short as ticket sale2024-05-22
Labour concedes it could have done more to deal with disruptive state housing tenants
Chris Hipkins said Labour had made some changes when in government to deal with disruptive Kāinga Or2024-05-22'He's almost like a LEAGUE TWO player': Roy Keane slams Erling Haaland for his display in City's 0
Roy Keane offered a scathing assessment of Erling Haaland's performance in Manchester City's 0-0 dra2024-05-22Tennessee latest state to mandate automatic defibrillators at high schools
NASHVILLE, Tenn. (AP) — NFL Commissioner Roger Goodell joined Gov. Bill Lee on Tuesday to celebrate2024-05-22ALISON BOSHOFF: Yo ho ho! Johnny Depp to launch his own brand of Caribbean dark rum
He's famous for loving booze — and now actor Johnny Depp is to launch his own brand of Caribbean rum2024-05-22
atest comment